• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    10/3/23 1:32:46 PM ET
    $ADAG
    $AGIL
    $ALXO
    $AONC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Professional Services
    Consumer Discretionary
    Get the next $ADAG alert in real time by email

    Gainers

    Vericity, Inc. (NASDAQ:VERY) shares climbed 87.4% to $11.12 after iA Financial Group announced it will acquire the company.

    POINT Biopharma Global Inc. (NASDAQ:PNT) surged 84.7% to $12.35. Eli Lilly And Co (NYSE:LLY) agreed to acquire POINT Biopharma Global at $12.50 per share in cash, an aggregate of approximately $1.4 billion.

    ALX Oncology Holdings Inc. (NASDAQ:ALXO) shares jumped 56% to $7.50 after the company released interim Phase 2 data from its ASPEN-06 trial of evorpacept in advanced HER2-positive gastric cancer.

    SeaStar Medical Holding Corporation (NASDAQ:ICU) gained 53.3% to $0.6398 after jumping 58% on Monday. SeaStar Medical was recently granted Breakthrough Device Designation by the FDA for its Selective Cytopheretic Device for Cardiorenal Syndrome.

    VIQ Solutions Inc. (NASDAQ:VQS) shares jumped 52% to $0.1991 after falling 18% on Monday. VIQ Solutions recently announced delisting from the Nasdaq.

    SciSparc Ltd. (NASDAQ:SPRC) shares gained 48.3% to $5.46 after the company announced it was granted a European patent for its core technology.

    Molekule Group, Inc. (NASDAQ:MKUL) shares climbed 43.6% to $0.2140.

    MSP Recovery, Inc. (NASDAQ:LIFW) shares climbed 41.3% to $0.2827 after falling around 7% on Monday.

    Delta Apparel, Inc. (NYSE:DLA) shares jumped 19.8% to $7.89 after the company said it received an unsolicited offer to purchase its Salt Life business.

    Rite Aid Corporation (NYSE:RAD) rose 15.6% to $0.5436. Rite Aid announced the arrival of Ello Market™ to its shelves.

    Summit Midstream Partners, LP (NYSE:SMLP) gained 15.4% to $15.75. Summit Midstream Partners expects third-quarter adjusted EBITDA of $70 million, up by 20% from the second quarter.

    Connexa Sports Technologies Inc. (NASDAQ:CNXA) climbed 14.6% to $3.5999.

    Adagene Inc. (NASDAQ:ADAG) gained 14.3% to $1.6350.

    Torrid Holdings Inc. (NYSE:CURV) rose 11.2% to $2.2453.

    Warby Parker Inc. (NYSE:WRBY) gained 10.4% to $14.65. Evercore ISI Group upgraded Warby Parker from In-Line to Outperform and announced a $20 price target.

    AgileThought, Inc. (NASDAQ:AGIL) shares climbed 10.3% to $0.1765 after gaining 9% on Monday.

    SPI Energy Co., Ltd. (NASDAQ:SPI) gained 10.3% to $0.79.

    Clean Energy Fuels Corp. (NASDAQ:CLNE) rose 9.5% to $3.9299. Raymond James upgraded Clean Energy Fuels from Outperform to Strong Buy and announced a $6 price target.

    CalAmp Corp. (NASDAQ:CAMP) gained 8.1% to $0.4499.

    Lantheus Holdings, Inc. (NASDAQ:LNTH) climbed 7.1% to $72.43 possibly after Eli Lilly agreed to acquire POINT Biopharma. Lantheus and POINT are partners for certain cancer programs.

    Oddity Tech Ltd. (NASDAQ:ODD) gained 4.8% to $29.42 after the company reported solid preliminary third-quarter results, allowing it to deliver net revenue growth of at least 58% in the first three quarters of 2023.

    Fiverr International Ltd. (NYSE:FVRR) rose 4.2% to $25.07. Roth MKM upgraded Fiverr Intl from Neutral to Buy and announced a $33 price target.

    Losers

    SmileDirectClub, Inc. (NASDAQ:SDC) dipped 39.7% to $0.0970 after the company reported it received notice that its securities will be delisted from the Nasdaq.

    Femasys Inc. (NASDAQ:FEMY) fell 34.3% to $2.5550 after gaining more than 30% on Monday.

    Momentus Inc. (NASDAQ:MNTS) dipped 32% to $1.2132. Momentus announced a $4.0 million registered direct offering priced at-the-market under Nasdaq rules.

    Power REIT (NYSE:PW) dipped 31.9% to $0.8170.

    Ocean Biomedical, Inc. (NASDAQ:OCEA) fell 30% to $2.45 as the company said its cancer-targeting immunotherapy antibody candidate demonstrated effective tumor reduction against an aggressive subset of Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor mutations.

    ShiftPixy, Inc. (NASDAQ:PIXY) fell 24.2% to $1.1599.

    Enhabit, Inc. (NYSE:EHAB) fell 23.2% to $9.01.

    The Dixie Group, Inc. (NASDAQ:DXYN) fell 23.1% to $0.53.

    WeWork Inc. (NYSE:WE) fell 22% to $2.2961. WeWork opted not to make aggregate interest payments totaling about $37.3 million in cash and $57.9 million in additional PIK notes, both due on October 2, 2023.

    The9 Limited (NASDAQ:NCTY) fell 21.5% to $3.8735.

    AERWINS Technologies Inc. (NASDAQ:AWIN) fell 19.2% to $0.1850. AERWINS Technologies shares jumped around 90% on Monday after the company said it is considering strategic alternatives for its non-core operations.

    PaxMedica, Inc. (NASDAQ:PXMD) declined 15.6% to $0.2746.

    OpGen, Inc. (NASDAQ:OPGN) shares fell 15.6% to $0.3540 after gaining 5% on Monday. OpGen recently requested to withdraw its registration statement on Form S-1.

    American Oncology Network, Inc. (NYSE:AONC) declined 14.7% to $7.57.

    Aris Mining Corporation (NYSE:ARMN) fell 14.6% to $2.21.

    Getty Images Holdings, Inc. (NYSE:GETY) declined 14.6% to $5.46 after Redburn Atlantic downgraded the stock from Buy to Neutral and announced a $6 price target.

    Conduit Pharmaceuticals Inc. (NASDAQ:CDT) fell 14.5% to $5.05.

    Marathon Digital Holdings, Inc. (NASDAQ:MARA) dipped 13.4% to $7.38.

    Hovnanian Enterprises, Inc. (NYSE:HOV) fell 11.1% to $90.81.

    Wayfair Inc. (NYSE:W) dipped 10% to $56.25.

    Cipher Mining Inc. (NASDAQ:CIFR) shares declined 9.7% to $2.2927 amid a pullback in Bitcoin. The company issued September operational update. The company produced 416 BTC in September, representing a 16% rise in production relative to the prior month.

    McCormick & Company, Incorporated (NYSE:MKC) fell 8.6% to $68.28 after the company reported worse-than-expected third-quarter sales results and issued guidance.

    Eastside Distilling, Inc. (NASDAQ:EAST) fell 8.5% to $1.5001 after gaining 33% on Monday. The company recently announced the successful completion of a debt-for-equity exchange with key first and second lien debt holders.

    DISH Network Corporation (NASDAQ:DISH) declined 8.4% to $5.12. Dish Network, on Oct. 2, entered into an amended and restated agreement and plan of merger with EchoStar and EAV Corp.

    Now Read This: Vivani Medical And 3 Other Stocks Under $2 Insiders Are Buying

    Get the next $ADAG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADAG
    $AGIL
    $ALXO
    $AONC

    CompanyDatePrice TargetRatingAnalyst
    ALX Oncology Holdings Inc.
    $ALXO
    3/6/2026$6.00Buy
    UBS
    Enhabit Inc.
    $EHAB
    3/6/2026$13.80Buy → Hold
    TD Cowen
    Fiverr International Ltd.
    $FVRR
    3/2/2026Buy → Neutral
    BTIG Research
    MARA Holdings Inc.
    $MARA
    2/27/2026Buy → Neutral
    H.C. Wainwright
    Lantheus Holdings Inc.
    $LNTH
    2/26/2026Mkt Perform → Outperform
    William Blair
    ODDITY Tech Ltd.
    $ODD
    2/26/2026$23.00Outperform → In-line
    Evercore ISI
    ODDITY Tech Ltd.
    $ODD
    2/26/2026$16.00Overweight → Neutral
    Analyst
    ODDITY Tech Ltd.
    $ODD
    2/26/2026$13.00Equal Weight → Underweight
    Barclays
    More analyst ratings

    $ADAG
    $AGIL
    $ALXO
    $AONC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    May 31, 2024 - FDA Roundup: May 31, 2024

    For Immediate Release: May 31, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA approved mRESVIA (Respiratory Syncytial Virus Vaccine) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. mRESVIA is an mRNA-based vaccine that is manufa

    5/31/24 3:22:42 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    May 7, 2024 - FDA Roundup: May 7, 2024

    For Immediate Release: May 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a meeting of the Psychopharmacologic Drugs Advisory Committee on June 4 to discuss a new drug application for midomafetamine (MDMA) capsules, submitted by Lykos Therapeutics, for the treatment of post-traumatic stress disorder. The committ

    5/7/24 4:10:24 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    December 5, 2023 - FDA Roundup: December 5, 2023

    For Immediate Release: December 05, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, registration opened for the FDA’s virtual Rare Disease Day on Friday, March 1, 2024. This year’s Rare Disease Day is dedicated to patients and health care professionals. Panels will discuss efforts to address the unique challenges with developing treat

    12/5/23 5:00:21 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADAG
    $AGIL
    $ALXO
    $AONC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Posner Henry Iii bought $162,929 worth of 7.75% Series A Cum. Red. Perpetual Preferred Stock (24,633 units at $6.61), increasing direct ownership by 263% to 34,000 units (SEC Form 4)

    4 - Power REIT (0001532619) (Issuer)

    2/10/26 2:53:54 PM ET
    $PW
    Real Estate Investment Trusts
    Real Estate

    Amendment: Large owner Posner Henry Iii bought $35,025 worth of 7.75% Series A Cum. Red. Perpetual Preferred Stock (4,797 units at $7.30) (SEC Form 4)

    4/A - Power REIT (0001532619) (Issuer)

    2/10/26 2:00:47 PM ET
    $PW
    Real Estate Investment Trusts
    Real Estate

    Large owner Posner Henry Iii bought $16,120 worth of 7.75% Series A Cum. Red. Perpetual Preferred Stock (2,022 units at $7.97), increasing direct ownership by 28% to 9,367 units (SEC Form 4)

    4 - Power REIT (0001532619) (Issuer)

    2/4/26 6:09:33 PM ET
    $PW
    Real Estate Investment Trusts
    Real Estate

    $ADAG
    $AGIL
    $ALXO
    $AONC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS resumed coverage on ALX Oncology with a new price target

    UBS resumed coverage of ALX Oncology with a rating of Buy and set a new price target of $6.00

    3/6/26 8:38:03 AM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Enhabit Inc. downgraded by TD Cowen with a new price target

    TD Cowen downgraded Enhabit Inc. from Buy to Hold and set a new price target of $13.80

    3/6/26 8:25:46 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Fiverr downgraded by BTIG Research

    BTIG Research downgraded Fiverr from Buy to Neutral

    3/2/26 8:54:59 AM ET
    $FVRR
    Real Estate

    $ADAG
    $AGIL
    $ALXO
    $AONC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    McCormick & Company to Report 2026 First Quarter Financial Results on March 31, 2026

    HUNT VALLEY, Md., March 10, 2026 /PRNewswire/ -- McCormick & Company, Incorporated (NYSE:MKC), a global leader in flavor, is scheduled to conduct a conference call and webcast of its first quarter 2026 financial results on Tuesday March 31, 2026, at 8:00 a.m. Eastern Time. Brendan Foley, Chairman, President & CEO; Marcos Gabriel, Executive Vice President & CFO; and Faten Freiha, Vice President of Investor Relations will be hosting the call. A live audio webcast of the call along with the accompanying presentation materials will be available on the McCormick website ir.mccormick.com. If you are unable to attend the live webcast, the presentation will be archived on the same website. To listen

    3/10/26 4:15:00 PM ET
    $MKC
    Packaged Foods
    Consumer Staples

    Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th

    NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum, taking place March 11–12, 2026. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER HERE Investors are encouraged to pre-register and run the online system check to expedite participation and receive event updates. Participation is free, and attendees may watch live company presentations and schedule one-on-one meetings with management teams. Schedule 1x1 meetings here "We are delighted to highlight today's innovators from the Life Science

    3/10/26 10:21:44 AM ET
    $AEMD
    $CVKD
    $DYAI
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Biotechnology: Biological Products (No Diagnostic Substances)

    SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails

    TEL AVIV, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), today announced that NeuroThera Labs Inc. (TSXV:NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, in which SciSparc holds a controlling interest of approximately 75%, has entered into a definitive share purchase agreement (the "SPA"), between NeuroThera, CliniQuantum Ltd. ("CliniQ") and the Selling Shareholders (as defined below) to acquire approximately 54.01% of the issued and outstanding ordinary shares of CliniQ (the "CliniQ Shares") on a fully diluted basis immediately prior to the closing

    3/10/26 9:28:00 AM ET
    $SPRC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADAG
    $AGIL
    $ALXO
    $AONC
    SEC Filings

    View All

    Amendment: SEC Form SC TO-I/A filed by Getty Images Holdings Inc.

    SC TO-I/A - Getty Images Holdings, Inc. (0001898496) (Subject)

    3/11/26 11:21:52 AM ET
    $GETY
    Real Estate

    SEC Form PRE 14A filed by Lantheus Holdings Inc.

    PRE 14A - Lantheus Holdings, Inc. (0001521036) (Filer)

    3/10/26 5:18:10 PM ET
    $LNTH
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    CDT Equity Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - CDT Equity Inc. (0001896212) (Filer)

    3/9/26 4:05:49 PM ET
    $CDT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADAG
    $AGIL
    $ALXO
    $AONC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Mcquiddy Collin covered exercise/tax liability with 592 shares, decreasing direct ownership by 10% to 5,394 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    3/10/26 9:32:55 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    SEC Form 4 filed by Enhabit Inc.

    4 - Enhabit, Inc. (0001803737) (Issuer)

    3/10/26 9:26:16 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    SEC Form 4 filed by Enhabit Inc.

    4 - Enhabit, Inc. (0001803737) (Issuer)

    3/10/26 9:26:55 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $ADAG
    $AGIL
    $ALXO
    $AONC
    Leadership Updates

    Live Leadership Updates

    View All

    Cipher Welcomes Thomas Duda to the Company's Board of Directors

    NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ:CIFR) ("Cipher" or the "Company"), a leading developer and operator of industrial-scale data centers, today announces the appointment of Thomas Duda to its Board of Directors. Mr. Duda has more than twenty years of real estate-focused investment experience, further strengthening the Board as Cipher executes its pivot to becoming a world leader in data center development and operations. Mr. Duda currently serves as Vice President of Real Estate at Henry Crown and Company, where he leads the firm's real estate investment and asset management activities, and is a member of the Investment and Management Committee. Previous

    2/11/26 4:05:00 PM ET
    $CIFR
    Finance: Consumer Services
    Finance

    Warby Parker Appoints Adrian Mitchell as Chief Financial Officer

    Warby Parker Inc. (NYSE:WRBY), a direct-to-consumer lifestyle brand focused on vision for all, today announced the appointment of Adrian Mitchell as Chief Financial Officer, effective February 10, 2026. His appointment strengthens Warby Parker's leadership team as the company continues executing its strategic vision, building on a track record of retail and product innovation while expanding into new categories, including the launch of its first AI glasses. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209259218/en/Adrian Mitchell, Chief Financial Officer Mitchell has more than 25 years of experience leading some of the worl

    2/9/26 4:10:00 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care

    Lilly to acquire Orna Therapeutics to advance cell therapies

    Orna's in vivo CAR-T pipeline includes potential best-in-class programs to reset the immune system and address B cell-driven autoimmune diseases Acquisition provides a broad platform for long-term innovation in genetic medicine and in vivo cell engineering INDIANAPOLIS and WATERTOWN, Mass., Feb. 9, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Orna Therapeutics, Inc., a biotechnology company dedicated to engineering immune cells in vivo, today announced entry into a definitive agreement for Lilly to acquire Orna. Orna is advancing a new class of therapeutics utilizing engineered circular RNA paired with novel lipid nanoparticles to allow the patient's own body to generate cell

    2/9/26 7:00:00 AM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADAG
    $AGIL
    $ALXO
    $AONC
    Financials

    Live finance-specific insights

    View All

    McCormick & Company to Report 2026 First Quarter Financial Results on March 31, 2026

    HUNT VALLEY, Md., March 10, 2026 /PRNewswire/ -- McCormick & Company, Incorporated (NYSE:MKC), a global leader in flavor, is scheduled to conduct a conference call and webcast of its first quarter 2026 financial results on Tuesday March 31, 2026, at 8:00 a.m. Eastern Time. Brendan Foley, Chairman, President & CEO; Marcos Gabriel, Executive Vice President & CFO; and Faten Freiha, Vice President of Investor Relations will be hosting the call. A live audio webcast of the call along with the accompanying presentation materials will be available on the McCormick website ir.mccormick.com. If you are unable to attend the live webcast, the presentation will be archived on the same website. To listen

    3/10/26 4:15:00 PM ET
    $MKC
    Packaged Foods
    Consumer Staples

    Torrid Announces Reporting Date for Fourth Quarter and Fiscal 2025 Financial Results

    Torrid Holdings Inc. ("Torrid" or the "Company") (NYSE:CURV), a direct-to-consumer apparel, intimates, and accessories brand in North America for women sizes 10 to 30, today announced that it will release fourth quarter and fiscal 2025 financial results after market close on Thursday, March 19, 2026. Management will host a conference call that afternoon at 4:30 p.m. Eastern Time to discuss its financial results. Those who wish to participate in the call may do so by dialing (877) 407-9208 or (201) 493-6784 for international callers. The conference call will also be webcast live at https://investors.torrid.com. For those unable to participate, a replay of the conference call will be avai

    3/5/26 4:05:00 PM ET
    $CURV
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Enhabit Reports Fourth Quarter 2025 Financial Results

    Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2025. "Our fourth quarter 2025 results capped a pivotal year for Enhabit, delivering an emerging growth story with year over year increases in patient census, revenue and Adjusted EBITDA," said Barb Jacobsmeyer, CEO and president of Enhabit. "The consistent execution of our strategy throughout the year materially improved free cash flow, enabling us to further strengthen our balance sheet, positioning us well to accelerate growth and investment in 2026." QUARTERLY PERFORMANCE - CONSOLIDATED Net service revenue of $270.4 million

    3/4/26 4:10:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $ADAG
    $AGIL
    $ALXO
    $AONC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MSP Recovery Inc.

    SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

    12/17/24 4:05:04 PM ET
    $LIFW
    EDP Services
    Technology

    SEC Form SC 13G filed by Torrid Holdings Inc.

    SC 13G - Torrid Holdings Inc. (0001792781) (Subject)

    12/12/24 6:06:52 PM ET
    $CURV
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Power REIT (MD)

    SC 13D/A - Power REIT (0001532619) (Subject)

    12/10/24 5:55:44 PM ET
    $PW
    Real Estate Investment Trusts
    Real Estate